يعرض 1 - 10 نتائج من 25 نتيجة بحث عن '"[18F]HX4"', وقت الاستعلام: 1.14s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    المساهمون: Precision Medicine, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

    المصدر: Clinical and Translational Radiation Oncology, Vol 23, Iss, Pp 9-15 (2020)
    Clinical and Translational Radiation Oncology
    Clinical and Translational Radiation Oncology, 23, 9-15. Elsevier Ireland Ltd

  7. 7

    المساهمون: Radiotherapie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Precision Medicine, RS: FSE DACS IDS, Institute of Data Science, Beeldvorming, MUMC+: DA Beeldvorming (5), RS: Carim - B06 Imaging, RS: GROW - R2 - Basic and Translational Cancer Biology, Radiology & Nuclear Medicine, Radiotherapy

    المصدر: Clinical and Translational Radiation Oncology, Vol 21, Iss, Pp 49-55 (2020)
    Clinical and Translational Radiation Oncology, 21, 49-55. Elsevier Ireland Ltd
    Clinical and Translational Radiation Oncology

    مصطلحات موضوعية: HX4-HV, HX4 hypoxic volume, medicine.medical_treatment, R895-920, HYPOXIA, NSCLC, 030218 nuclear medicine & medical imaging, TTD, total tumour dose, chemistry.chemical_compound, Nitroglycerin, Medical physics. Medical radiology. Nuclear medicine, 0302 clinical medicine, NECK-CANCER, Clinical endpoint, Medicine, SUVmax, maximum standardised uptake value, MFS, metastasis-free survival, RC254-282, HX4, GTV, gross tumour volume, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, GTVp, gross tumour volume of the primary tumour, HX4-HF, HX4 hypoxic fraction, CHEMOTHERAPY, 3. Good health, TBR, tumour-to-blood ratio, Mitochondria, Perfusion, Oncology, 030220 oncology & carcinogenesis, HX4, 2-nitroimidazole [18F]-HX4 (flortanidazole, 3-[18F]fluoro-2-(4-((2-nitro-1Himidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-propan-1-ol), cardiovascular system, medicine.symptom, circulatory and respiratory physiology, RADIOTHERAPY, Radiosensitizer, medicine.medical_specialty, FHV, fraction of hypoxic volume hypoxic fraction of the GTV, Urology, LRPFS, loco-regional progression free survival, Article, PET, positron emission tomography, OS, overall survival, 03 medical and health sciences, SDG 3 - Good Health and Well-being, NSCLC, non-small cell lung cancer, CoR, coefficient of repeatability, Radiology, Nuclear Medicine and imaging, cardiovascular diseases, Lung cancer, BV, blood volume, IQR, interquartile range, Chemotherapy, NO, nitric oxide, CARBOPLATIN, NITRIC-OXIDE, business.industry, CONCURRENT, INDAR, individualized accelerated radiotherapy, BF, blood flow, STAGE IIIA, Hypoxia (medical), medicine.disease, Carboplatin, respiratory tract diseases, DCE-CT, dynamic contrast-enhanced CT, Radiation therapy, CI, confidence interval, PET, chemistry, GTVln, gross tumour volume of the lymph nodes, SUVmean, mean standardised uptake value, business

    وصف الملف: application/pdf

  8. 8
  9. 9
  10. 10